Clinical trial
The Drug Interaction Study of SP2086 and Simvastatin in Healthy Subjects
NCT02817243 is registered in ClinicalTrials.gov with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Drug Interaction Study of SP2086 and Simvastatin in Healthy Subjects
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- March 31, 2016
- Completion date
- Not reported
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes